Washington, DC – September, 12, 2012) Galileo Analytics Co-Founder Anna McCollister-Slipp will be speaking at AdvaMed 2012, discussing the need for manufacturers to incorporate product data access and integration into the core elements of medical device design.
McCollister-Slipp will join other industry experts on a panel addressing the impact of regulation on the growing demand and use of health information technology, specifically as it relates to accessing and using device-generated data.
Complete panel information is below:
Impact of Health IT Regulations on IndustryTuesday, October 2, 2012 9:15 am – 10:30 am Panel Location: 160A
Healthcare decision-makers are increasingly prioritizing Health IT, often at the expense of other budgets and even impacting the purchasing process of non-IT products. This poses a challenge for many medical device companies with limited Health IT experience or with a lack of familiarity with this rapidly evolving space. However, this also presents an opportunity for companies to use a forward-looking IT alignment strategy as a competitive advantage. Our panelists will highlight key examples of success and outline some demonstrated best practices.
- Shami Feinglass MD, MPH, Vice President, Global Medical & Regulatory Affairs, Zimmer, Inc.
- Anna McCollister-Slipp, Co-Founder, Galileo Analytics
- Robert Jarrin, Senior Director, Government Affairs, Qualcomm Incorporated
- Patricia Katzman, Director, Interoperability & CDS Marketing and Strategy, Philips Healthcare Patient Care & Clinical Informatics